Metformin × costs & health-care use

SynthesisCanadian respiratory journal2020

Association of Metformin Use with Asthma Exacerbation in Patients with Concurrent Asthma and Diabetes: A Systematic Review and Meta-Analysis of Observational Studies.

Li Wen et al.PubMed ↗Full text ↗Publisher ↗

What moved togetherboth groups pooled, not the treatment’s effect

Correlation · may be no link

No clear link with costs & health-care use

−35%−72% to +48%

Bigger than 7 in 10 on the map

As reported

OR 0.65, 95% CI 0.28–1.48

One number in the abstract

the abstract, start to end

with a risk of asthma exacerbation (OR = 0.65, 95% CI 0.28-1.48; Conclusion:

← favours treatmentfavours comparator →
could be chance
Costs & health-care use
OR 0.650.28–1.48
MetforminCosts & health-care use
1 / 3

13 papers cite it

2020
2021
2022
2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 32831980